Targeting Dengue Virus Using Artificial MicroRNAs

Mosquito-borne dengue viruses cause an estimated 50 million cases of human dengue fever a year and are a significant public health threat worldwide. A novel therapeutic approach prevents dengue virus from reproducing in humans by targeting and silencing key regions of the dengue genome essential for viral replication. This innovative treatment strategy and the successful results of initial testing are presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers. The article is available on the Nucleic Acid Therapeutics website...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/YdPn7BBudK8/263298.php

auto sport medical rehab